JP2004512021A - ミクロサテライト不安定（ｍｓｉ＋）腫瘍に適切な遺伝子およびその遺伝子産物 - Google Patents

ミクロサテライト不安定（ｍｓｉ＋）腫瘍に適切な遺伝子およびその遺伝子産物 Download PDF

Info

Publication number
JP2004512021A
JP2004512021A JP2002509517A JP2002509517A JP2004512021A JP 2004512021 A JP2004512021 A JP 2004512021A JP 2002509517 A JP2002509517 A JP 2002509517A JP 2002509517 A JP2002509517 A JP 2002509517A JP 2004512021 A JP2004512021 A JP 2004512021A
Authority
JP
Japan
Prior art keywords
msi
gene
tumor
cells
cmnr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002509517A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004512021A5 (https=
Inventor
クネーベル　デーベリッツ，フォン，マグヌス
ボーク，ピーア
ユアン，ヤン，ピン
ゲベルト，ヨハネス
ヴェルナー，シュテファン
リンネバッハー，ミヒャエル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2004512021A publication Critical patent/JP2004512021A/ja
Publication of JP2004512021A5 publication Critical patent/JP2004512021A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP2002509517A 2000-07-07 2001-07-04 ミクロサテライト不安定（ｍｓｉ＋）腫瘍に適切な遺伝子およびその遺伝子産物 Pending JP2004512021A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10032608A DE10032608A1 (de) 2000-07-07 2000-07-07 Für mikrosatelliteninstabile (MSI+)-Tumore relevante Gene und ihre Genprodukte
PCT/DE2001/002510 WO2002004664A2 (de) 2000-07-07 2001-07-04 Aus tumorzellen isolierbare gene mit kodierenden mononucleotid- oder dinucleotid-mikrosatelliten

Publications (2)

Publication Number Publication Date
JP2004512021A true JP2004512021A (ja) 2004-04-22
JP2004512021A5 JP2004512021A5 (https=) 2005-02-17

Family

ID=7647836

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002509517A Pending JP2004512021A (ja) 2000-07-07 2001-07-04 ミクロサテライト不安定（ｍｓｉ＋）腫瘍に適切な遺伝子およびその遺伝子産物

Country Status (8)

Country Link
US (1) US20040265803A1 (https=)
EP (1) EP1352088A2 (https=)
JP (1) JP2004512021A (https=)
AU (1) AU2001281708A1 (https=)
CA (1) CA2415199A1 (https=)
DE (1) DE10032608A1 (https=)
NO (1) NO20030052L (https=)
WO (1) WO2002004664A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1361286A1 (en) * 2002-04-18 2003-11-12 MTM Laboratories AG Method for detection of cancer
AU2003232485A1 (en) 2002-04-18 2003-10-27 Mtm Laboratories Ag Neopeptides and methods useful for detection and treatment of cancer
EP1354895A1 (en) * 2002-04-18 2003-10-22 MTM Laboratories AG Neopeptides useful for detection and treatment of cancer
CA2651796A1 (en) * 2006-02-27 2007-09-07 Arizona Board Of Regents For And On Behalf Of Arizona State University Identification and use of novopeptides for the treatment of cancer
US9732131B2 (en) * 2006-02-27 2017-08-15 Calviri, Inc. Identification and use of novopeptides for the treatment of cancer
JP2019505512A (ja) 2016-01-08 2019-02-28 バッシボディ アクスイェ セルスカプ 治療用抗癌ネオエピトープワクチン
US20200276285A1 (en) 2017-06-02 2020-09-03 Arizona Board Of Regents On Behalf Of Arizona State University A method to create personalized cancer vaccines
US12025615B2 (en) 2017-09-15 2024-07-02 Arizona Board Of Regents On Behalf Of Arizona State University Methods of classifying response to immunotherapy for cancer
EP4038222A4 (en) 2019-10-02 2023-10-18 Arizona Board of Regents on behalf of Arizona State University Methods and compositions for identifying neoantigens for use in treating and preventing cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741650A (en) * 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
AU744157B2 (en) * 1997-07-28 2002-02-14 Fox Chase Cancer Center Novel gene encoding a DNA repair endonuclease and methods of use thereof
CA2417866A1 (en) * 2000-08-03 2002-02-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer

Also Published As

Publication number Publication date
NO20030052D0 (no) 2003-01-06
WO2002004664A3 (de) 2003-06-19
AU2001281708A1 (en) 2002-01-21
WO2002004664A2 (de) 2002-01-17
NO20030052L (no) 2003-03-07
CA2415199A1 (en) 2003-01-07
US20040265803A1 (en) 2004-12-30
WO2002004664A9 (de) 2002-09-19
DE10032608A1 (de) 2002-01-24
EP1352088A2 (de) 2003-10-15

Similar Documents

Publication Publication Date Title
CN109790583B (zh) 对肺腺癌亚型分型的方法
EP1064372B1 (en) Compounds and methods for therapy and diagnosis of lung cancer
EP1272668A2 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
WO1998004689A1 (en) Biomarkers and targets for diagnosis, prognosis and management of prostate disease
WO2003101283A2 (en) Diagnostics markers for lung cancer
CN1333830A (zh) 用于治疗和诊断卵巢癌的组合物和方法
CN1646692B (zh) 在肿瘤中差异表达的基因产物及其用途
JP7751817B2 (ja) 新規な癌抗原及び方法
JP2004512021A (ja) ミクロサテライト不安定（ｍｓｉ＋）腫瘍に適切な遺伝子およびその遺伝子産物
US20060134682A1 (en) Preparation and use of superior vaccines
US20020192647A1 (en) Diagnostic method
JP2004535181A (ja) ＩＦＮα−１４遺伝子の新しいポリヌクレオチド及びポリペプチド
CA2335452A1 (en) Preparation and use of superior vaccines
CN101525656A (zh) 强直性脊柱炎易感性检测方法和试剂盒
US5652357A (en) Nucleic acids for the detection of the Bak polymorphism in human platelet membrane glycoprotein IIb
CN1646703A (zh) 诊断和治疗与人转酮酶样－1基因过表达有关的增殖异常的组合物和方法
WO2001022864A9 (en) Sequences characteristic of bladder cancer
JP3524537B2 (ja) 癌の診断、モニタリング、ステージング、イメージングおよび処置のための新規方法
Cox et al. Sequence of HLA-A* 0209 confirmed.
JP4219027B2 (ja) 全身性エリテマトーデスの判定法およびその診断キット
JP2009195236A (ja) 乳癌の免疫療法および診断のための化合物ならびにそれらの使用のための方法
EP1185547A2 (en) Gene expression modulated in gastrointestinal inflammation
HK1044021A1 (zh) 用於治療和診斷卵巢癌的組合物和方法
WO2000029621A2 (en) Method for measuring target polynucleotides and novel asthma biomolecules
EP2003201A2 (en) Compounds and methods for therapy and diagnosis of lung cancer

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060123

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20060421

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20060501

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20061003